<DOC>
	<DOCNO>NCT01960530</DOCNO>
	<brief_summary>This study investigate new drug call Infacort® ; newly-developed immediate release formulation well-established drug call hydrocortisone . Hydrocortisone use replacement treatment people whose adrenal gland produce enough natural cortisol - condition know adrenal insufficiency . The study ass Infacort® act inside body , measure cortisol hormone level body , compare already market hydrocortisone tablet hydrocortisone intravenous ( vein ) injection . The population eligible take part study healthy male volunteer , age 18 60 year age .</brief_summary>
	<brief_title>An Investigational Study Hydrocortisone</brief_title>
	<detailed_description>The study evaluate normal physiology , PK metabolism cortisol , investigate PK bioavailability cortisol test Infacort® Granules ( hydrocortisone ) reference hydrocortisone tablet i.v injection healthy adult male volunteer explore role cortisol regulation metabolic pathway .</detailed_description>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Healthy male volunteer 18 60 year age , inclusive ( screen ) . Subjects Body Mass Index ( BMI ) 2128 . Body Mass Index = Body weight ( kg ) / ( Height ( ) 2 . Subjects clinically significant abnormal serum biochemistry , haematology urinalysis value within 14 day prior Day 1 Study Period 1 . Subjects negative urinary drug abuse screen , determine within 14 day prior Day 1 Study Period 1 . A positive alcohol test may repeat discretion Investigator . Subjects negative HIV Hepatitis B C result . Subjects clinically significant abnormality 12lead electrocardiogram ( ECG ) determine within 14 day prior Day 1 Study Period 1 . Subjects clinicallysignificant deviation outside normal range blood pressure pulse measurement . Subjects ( unless anatomically sterile abstain sexual intercourse line prefer usual lifestyle subject ) sexual partner must use effective contraception method trial 3 month last dose , example : Oral contraceptive + condom Intrauterine device ( IUD ) + condom Diaphragm spermicide + condom Subjects must available complete study . Subjects must satisfy medical examiner fitness participate study . Subjects must provide write informed consent participate study . A clinically significant history gastrointestinal disorder likely influence drug absorption . Receipt regular medication within 14 day prior Day 1 Study Period 1 ( include high dose vitamin , dietary supplement herbal remedy ) . Receipt vaccination within 14 day prior Day 1 Study Period 1 . Evidence renal , hepatic , central nervous system , respiratory , cardiovascular metabolic dysfunction . Presence clinically significant infection ( systemic fungal viral infection , acute bacterial infection ) . Current previous history tuberculosis . A clinically significant history previous allergy / sensitivity Hydrocortisone and/or Dexamethasone . A clinically significant history family history psychiatric disorders/illnesses . A clinically significant history drug alcohol abuse . Inability communicate well Investigator ( i.e. , language problem , poor mental development impair cerebral function ) . Participation New Chemical Entity clinical study within previous 4 month market drug clinical study within previous 3 month . ( N.B . The washout period trial define period time elapse last dose previous study first dose next study ) Subjects consumed 2 unit alcohol per day within seven ( 7 ) day prior Day 1 Study Period 1or consume alcohol within 48 hour period prior Day 1 Study Period 1 . Donation 450ml blood within previous 3 month . Subjects smoke ( exsmokers smoke within 6 month prior Day 1 Study Period 1 ) . Subjects work shift ( i.e . regularly alternate day , afternoon night ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>